
Avivo is on a mission to save lives by increasing the number of organ transplants and expanding the available blood supply. Our enzymes eliminate the blood type barrier in blood transfusion and organ transplantation by converting all blood types to Type O, the universal donor type. As a dual-use technology, Avivo sits at the intersection of military trauma and donor organ utilization. In a world first, the company has completed its proof-of-concept study by implanting an Enzyme Converted Type O (ECO) organ into a blood type mismatched human decedent kidney transplant model and is advancing…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.